Unlike widely covered large caps, Myseum.AI (MYSE) has effectively no established sell-side price-target coverage. Aggregators show no reliable consensus target, and the single rating in circulation — a "Sell (D-)" from Weiss Ratings — is a model-based letter grade, not a dollar price target. Because a meaningful analyst-derived mean cannot be assembled, this article does not present a fabricated consensus. Instead, the $1.50 objective reflects public technical discussion: the stock traded between roughly $1.31 and $1.40 in late October and early November 2026, and $1.50 sits between that recent range and the 50-day moving average near $1.82. It is a recovery milestone, not an analyst forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares closed near $1.06, near the bottom of a 52-week range of $1.06 to $5.77, after falling from about $1.37 in roughly two weeks. Reaching $1.50 would require a gain of about 42%, which is a very large move for any security and especially so for a thinly traded micro-cap. The path would likely depend on the company converting its technology platform into actual user growth and revenue, stabilizing its cash burn, and rebuilding investor confidence after a prolonged slide in the share price. At a market capitalization around $5.5 million, even modest news flow can produce outsized percentage moves in either direction.
The 52-week high of $5.77 and low of $1.06 frame an extremely wide range, underscoring the stock's volatility. The 50-day moving average near $1.82 and the 200-day moving average near $2.04 both sit above the current price, meaning the stock remains in a longer-term downtrend. A decisive move back above the recent $1.31 to $1.40 area would be an early sign of stabilization, while the $1.50 level represents a round-number recovery milestone that also aligns with prior trading activity.
Because no formal analyst targets exist, there is no standard 12-month research horizon to apply here. The $1.50 objective is best understood as a technical recovery level rather than a dated forecast. Investors should watch for signs of revenue traction and user adoption, quarterly cash-burn rates, any capital raises or share issuance, and whether the stock can hold above recent lows. Broader risk appetite for speculative micro-caps and interest-rate expectations are also relevant to sentiment for this kind of security.
In my research on thinly traded names, I have found Tickeron’s AI Daily Buy/Sell Signals helpful for spotting shifts in technical conditions. The tool applies AI to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on market data and pattern recognition. For something as volatile as MYSE, it offers a way to monitor trend changes without relying solely on manual charts, serving as a practical complement to fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MYSE saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned negative. In 92 of the 102 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The 50-day moving average for MYSE moved below the 200-day moving average on October 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYSE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for MYSE entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for MYSE just turned positive on October 09, 2026. Looking at past instances where MYSE's MACD turned positive, the stock continued to rise in 37 of 41 cases over the following month. The odds of a continued upward trend are 90%.
Following a +1.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where MYSE advanced for three days, in 169 of 196 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
MYSE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. MYSE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.497) is normal, around the industry mean (-1.906). P/E Ratio (-1.008) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. MYSE's P/S Ratio (10000.000) is very high in comparison to the industry average of (70.383).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYSE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware